That question was addressed in a study recently published, drawn from a large database of three registries. The abstract is worded in a way that is very hard to make sense of and you have to dive into the body of the paper to get real answers. It turns out that patients who had anticoagulation restarted (at a median time of around a month) did better in terms of not only ischemic events but a composite outcome which included recurrent ICH. The rate of ICH itself was not significantly different between those who did and those who did not have anticoagulation resumed.
No comments:
Post a Comment